Gastric ulceration in horses: etiology, diagnosis, and therapy: a review
Abstract
Since it has become possible to make an ante-mortem diagnosis of gastric ulceration in horses by means of endoscopy, interest in the presence and treatment of this syndrome has increased. Several endoscopic surveys have indicated that the frequency of gastric ulceration in Thoroughbreds in training is fairly high. Less is known about other breeds and horses that are kept under different (training) conditions. The equine stomach is covered by two different kinds of mucous membranes: squamous and glandular. These two areas differ from one another in the incidence and aetiology of ulceration and, therefore, the therapeutic approach is not similar. Clinical signs that typically are associated with gastric ulceration include recurrent colic, poor appetite, weight loss, and, in foals, diarrhoea. Often symptoms are less obvious (such as poor performance), or not even noticeable. Treatment is possible with, for example, H2-antagonists or proton pump inhibitors. Management measurements are important in preventing ulcer recurrence.
How strong is the evidence?
Evidence Hub reads this as a review, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.